Timing for the Resumption of Anticoagulants after Intracranial Hemorrhage
The findings suggest that approximately 3 weeks after sICH is the optimal time to resume anticoagulants, minimizing the risk of rebleeding or thromboembolic events. These findings may inform clinical decision-making in a broad patient population, though individualized assessment remains essential.
Authors
- Sejin Choi (ORCID: https://orcid.org/0000-0001-8123-5685)
- Won‐Sang Cho (ORCID: https://orcid.org/0000-0002-3345-8718)
- Jeong Eun Kim (ORCID: https://orcid.org/0000-0002-6927-3109)
- Sung Ho Lee (ORCID: https://orcid.org/0000-0002-1018-7871)
- Kang Min Kim (ORCID: https://orcid.org/0000-0002-7409-4412)
- Myoung‐jin Jang (ORCID: https://orcid.org/0000-0001-8123-5001)
- Hyun‐Seung Kang (ORCID: https://orcid.org/0000-0002-6957-1907)
Institutions
- Shaikh Khalifa Medical City (AE)
- Seoul National University Hospital (KR)
Publication Details
- Journal
- Journal of Korean Neurosurgical Society
- Published
- 2025-09-02
- DOI
- https://doi.org/10.3340/jkns.2025.0112
- Citations
- 1
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Seoul National University